Coronavirus Disease 2019 (COVID-19), caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), has created a global pandemic infecting over 230 million …

Cenicriviroc (CVC) is a small-molecule chemokine receptor antagonist with highly potent
and selective anti-human immunodeficiency virus type 1 (HIV-1) activity through …

Objective Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
now a global pandemic. Emerging results indicate a dysregulated immune response. Given …

The chemokine receptor CCR5 has been implicated in COVID-19. CCR5 and its ligands are
overexpressed in patients. The pharmacological targeting of CCR5 would improve the …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is cause of the novel
coronavirus disease (COVID-19). In the last two years, SARS-CoV-2 has infected millions of …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a historic
pandemic of respiratory disease (coronavirus disease 2019 [COVID-19]), and current …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), is now pandemic with nearly three million cases …

Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the
SARS-CoV-2 betacoronavirus and has taken over 761,426 American lives as of the date of …

The recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus, the cause of coronavirus disease (COVID-19) and the associated ongoing pandemic …

An exacerbated and unbalanced immune response may account for the severity of COVID-
19, the disease caused by the novel severe acute respiratory syndrome (SARS) coronavirus …